Healthcare IT Today December 6, 2024
Healthcare IT News

Investments will Support New Product Offerings, US Expansion, and Development of Pathology Foundation Models

Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced today that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, fuel growth within the United States (US), and develop leading foundation models for pathology in collaboration with Mayo Clinic. The oversubscribed funding round was led by ATHOS, with investments from Mayo Clinic and growth financing from HTGF, alongside support from existing investors Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund, and VC Fonds Technologie managed by IBB Ventures. In total, Aignostics has now raised...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Investments, Pharma / Biotech, Precision Medicine, Technology, Trends
Related Articles:
Long-Read Sequencing Reveals Genetic Source of Rare Diseases
Diaceutics and Cornerstone AI Partner to Enhance Lab Data for Precision Medicine
Precision Medicine: Becoming More Real With AI?
Truveta Genome Project to Create Largest, Most Diverse Genomic Database with AI
Truveta and 30 health systems increase genomic sequencing goal

Share This Article